AMINOGRAM

Aminogram specializes in medical bioimpedance devices. Specifically, it produces the Biody XPERTZM 3, a device designed for clinical analysis of body composition. This includes measuring parameters like fat mass, lean tissue, and hydration status using bioimpedance technology, which helps healthcare professionals assess patient health in diagnostic and monitoring contexts.

Aminogram is based in France. The company focuses on advancing the science of body composition through medical bioimpedance solutions, aiming to provide clinically relevant insights for healthcare providers. Its primary product, the Biody XPERTZM 3, is tailored for precise, non-invasive body composition analysis in medical settings.

Aminogram’s devices are listed in the EU’s eudamed database, which is the official registry for medical devices within the European Union. This registration ensures transparency and compliance with EU medical device regulations, though it does not imply approval—only that the device is accounted for in the system.

The Biody XPERTZM 3, Aminogram’s primary device, is classified as a Class IIa medical device. This classification is determined by its intended use and associated risk level, with Class IIa devices requiring compliance with specific EU regulations to ensure safety and performance, such as conforming to relevant harmonized standards and undergoing rigorous design controls.